富勒伦醇减轻辐射诱导的心肌损伤
Tingjun Zhang1,2, Rendong He1,3, Xuefeng Ding1,4
1Academician Workstation, Affiliated Hospital of North Sichuan Medical College Nanchong, Nanchong, 637000, P. R. China.
Advanced healthcare materials
|September 12, 2023
概括
富勒伦醇通过清除自由基和减少亡来保护心脏细胞免受辐射损伤. 这些发现为预防辐射引起的心脏病提供了有希望的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 纳米医学是一种纳米医学.
- 辐射瘤学 辐射瘤学
背景情况:
- 放射治疗可能会导致严重的心脏损伤,有效的预防和治疗选择有限.
- 辐射诱导的心脏病是一个重大的临床挑战.
- 迫切需要新的心脏保护剂.
研究的目的:
- 调查富勒伦醇对辐射诱导的心肌细胞损伤的保护作用.
- 探索富勒伦醇作为自由基清除剂和用于心脏保护的抗氧化剂.
- 评估富勒伦醇在减轻心肌损伤方面的治疗潜力.
主要方法:
- 通过基质催化方法合成富勒伦醇.
- 在体外评估富勒伦醇的抗氧化和自由基清除特性.
- 细胞研究以确定富勒伦醇通过线粒体通路对亡的作用.
- 在动物模型中进行体内评估,以评估心脏积累和心脏保护功效.
主要成果:
- 富勒伦醇成功合成,并显示出强大的自由基清除和抗氧化活性.
- 富勒伦醇通过线粒体信号通路显著降低了心肌细胞中X射线诱导的亡.
- 动物研究证实了富勒在心脏中的积累,并显著缓解了辐射后心肌损伤.
结论:
- 富勒伦醇对抗辐射损伤具有显著的心脏保护作用.
- 富勒伦醇是一种有前途的治疗策略,用于预防和治疗辐射引起的心脏病.
- 这项研究强调了富勒伦醇在放射治疗患者的临床应用中的潜力.
相关概念视频
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460


